Cargando…
Systemic Biomarkers and Unique Pathways in Different Phenotypes of Heart Failure with Preserved Ejection Fraction
Heart failure with preserved ejection fraction (HFpEF) accounts for around 50% of all heart failure cases. It is a heterogeneous condition with poorly understood pathogenesis. Here, we aimed to identify unique pathogenic mechanisms in acute and chronic HFpEF and hypertrophic cardiomyopathy (HCM). We...
Autores principales: | Chen, Hao, Tesic, Milorad, Nikolic, Valentina N., Pavlovic, Milan, Vucic, Rada M., Spasic, Ana, Jovanovic, Hristina, Jovanovic, Ivana, Town, Stephanie E. L., Padula, Matthew P., McClements, Lana |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9599828/ https://www.ncbi.nlm.nih.gov/pubmed/36291628 http://dx.doi.org/10.3390/biom12101419 |
Ejemplares similares
-
FK506-Binding Protein like (FKBPL) Has an Important Role in Heart Failure with Preserved Ejection Fraction Pathogenesis with Potential Diagnostic Utility
por: Chhor, Michael, et al.
Publicado: (2023) -
Maternal plasma proteome profiling of biomarkers and pathogenic mechanisms of early-onset and late-onset preeclampsia
por: Chen, Hao, et al.
Publicado: (2022) -
Association between Galectin-3 levels within central and peripheral venous blood, and adverse left ventricular remodelling after first acute myocardial infarction
por: Andrejic, Olivera M., et al.
Publicado: (2019) -
Galectin-3 as a Prognostic Biomarker in Patients with First Acute Myocardial Infarction without Heart Failure
por: Vucic, Rada M., et al.
Publicado: (2023) -
Trend of Galectin-3 Levels in Patients with Non-ST-Elevation and ST-Elevation Myocardial Infarction
por: Mitić, Branka, et al.
Publicado: (2022)